Variant report
Variant | esv1832991 |
---|---|
Chromosome Location | chr9:11353358-11375594 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546431156 | chr9:11353410-11353411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566656226 | chr9:11353453-11353454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190428073 | chr9:11353499-11353500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76147472 | chr9:11353506-11353507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2152261 | chr9:11353512-11353513 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs571313004 | chr9:11353559-11353560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568777819 | chr9:11353562-11353563 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548969327 | chr9:11353594-11353595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537815555 | chr9:11353598-11353599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554581560 | chr9:11353611-11353612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571032298 | chr9:11353719-11353720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574617685 | chr9:11353722-11353723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533860616 | chr9:11353735-11353736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150494993 | chr9:11353736-11353737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76198374 | chr9:11353760-11353761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577321410 | chr9:11353782-11353783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546189279 | chr9:11353805-11353806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563161401 | chr9:11353862-11353863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145641987 | chr9:11353866-11353867 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541857148 | chr9:11353868-11353869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561739020 | chr9:11353899-11353900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527828176 | chr9:11353901-11353902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17184286 | chr9:11353902-11353903 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs114410131 | chr9:11353956-11353957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532301724 | chr9:11353966-11353967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552212145 | chr9:11354019-11354020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs16927402 | chr9:11354069-11354070 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs535114074 | chr9:11354086-11354087 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138171536 | chr9:11354103-11354104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182639815 | chr9:11354142-11354143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs16927403 | chr9:11354168-11354169 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs142021271 | chr9:11354183-11354184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571917739 | chr9:11354196-11354197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539993294 | chr9:11354253-11354254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556465813 | chr9:11354270-11354271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536703387 | chr9:11354272-11354273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576370113 | chr9:11354287-11354288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556928249 | chr9:11354314-11354315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372176509 | chr9:11354317-11354318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150684512 | chr9:11354328-11354329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555344211 | chr9:11354397-11354398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139971863 | chr9:11354398-11354399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541185077 | chr9:11354404-11354405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79245196 | chr9:11354409-11354410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533248350 | chr9:11354604-11354605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571897882 | chr9:11354607-11354608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557728070 | chr9:11354660-11354661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546011986 | chr9:11354663-11354664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562532177 | chr9:11354704-11354705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528957137 | chr9:11354706-11354707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11351800-11353600 | Weak transcription | Brain Germinal Matrix | brain |
2 | chr9:11353000-11353400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr9:11353000-11355600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr9:11353400-11356600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr9:11353600-11353800 | Enhancers | Fetal Brain Male | brain |
6 | chr9:11353600-11354000 | Enhancers | Brain Germinal Matrix | brain |
7 | chr9:11353800-11354800 | Weak transcription | Fetal Brain Male | brain |
8 | chr9:11354000-11355200 | Weak transcription | Brain Germinal Matrix | brain |
9 | chr9:11354800-11356200 | Enhancers | Fetal Brain Male | brain |
10 | chr9:11355200-11356400 | Enhancers | Brain Germinal Matrix | brain |
11 | chr9:11355600-11356200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr9:11355800-11356200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr9:11355800-11356600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr9:11356000-11356400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr9:11356000-11356400 | Enhancers | Fetal Brain Female | brain |
16 | chr9:11366600-11367000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr9:11366800-11367000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr9:11367000-11370800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr9:11372800-11377200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr9:11374800-11375400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr9:11374800-11375600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
22 | chr9:11374800-11375600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
23 | chr9:11375000-11375400 | Enhancers | H9 Cell Line | embryonic stem cell |
24 | chr9:11375000-11375400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
25 | chr9:11375000-11375600 | Enhancers | HUES6 Cell Line | embryonic stem cell |